Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
VIC DRUG ALERT JUNE 2022
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Special K: What the Real Scoop on Abuse and Addiction to Ketamine? - Women's Recovery
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Special K: What the Real Scoop on Abuse and Addiction to Ketamine? - Women's Recovery
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Use of Ketamine in Hospitalized Patients - The Hospitalist
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
κ-opioid receptor - Wikipedia
Frontiers | Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
